BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Income Statement
NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 2.73M | 2.81M | 7.37M | 14.97M | 8.80M | |||
| Research and Development | 2.26M | 1.47M | 5.00M | 12.18M | 6.31M | |||
| Selling, General, and Administrative Expenses | 1.65M | 1.56M | 2.29M | 2.79M | 2.47M | |||
| Operating Income | -2.73M | -2.81M | -7.37M | -14.97M | -8.80M | |||
| Interest Income/Expense | 1.66M | 11.90K | -5.60K | 10.00K | 154.10K | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -2.00K | N/A | |||
| Income Before Taxes | -1.07M | -2.80M | -7.37M | -14.96M | -8.65M | |||
| Net Income | -1.07M | -2.80M | -7.37M | -14.96M | -8.65M | |||
| EBITDA | -2.65M | -2.74M | -7.29M | -14.97M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.24 | -0.65 | -1.98 | -6.06 | -4.82 | |||
| Statistics | ||||||||
All data in CAD